As of 2025-07-08, the Intrinsic Value of Atossa Therapeutics Inc (ATOS) is -1.02 USD. This Atossa valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.85 USD, the upside of Atossa Therapeutics Inc is -220.57%.
Based on its market price of 0.85 USD and our intrinsic valuation, Atossa Therapeutics Inc (ATOS) is overvalued by 220.57%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.02 - -1.02 | -1.02 | -220.57% |
| P/E | (0.14) - (2.63) | (1.41) | -267.0% |
| DDM - Stable | (1.16) - (4.09) | (2.63) | -410.4% |
| DDM - Multi | (0.92) - (2.73) | (1.40) | -265.8% |
| Market Cap (mil) | 109.25 |
| Beta | 2.36 |
| Outstanding shares (mil) | 129.17 |
| Enterprise Value (mil) | 44.14 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.40% |
| Cost of Debt | 5.00% |
| WACC | 8.03% |